Member Login
  1. Stocks
    2. /
  2. Moderna, Inc. (NasdaqGS: MRNA)
    3. /

NasdaqGS:MRNA (Moderna, Inc.)

About MRNA

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Moderna, Inc. (NasdaqGS: MRNA) Latest News

    Syringe and vial on blue background
    Investing Articles

    Is Moderna stock set for an explosive rise in 2023?

    | Ben McPoland

    Moderna stock is marching higher today after the company reported positive phase 3 data for its RSV vaccine. Can this…

    Read more »

    Syringe and vial on blue background
    Growth Shares

    Can Moderna stock triple my money this year?

    | John Choong

    Moderna stock has been plummeting. But with new treatments, one analyst is predicting a 300% jump. So, should I buy…

    Read more »

    Bournemouth at night with a fireworks display from the pier
    Investing Articles

    My 3 best stocks to buy in 2023

    | Ben McPoland

    Here's my three best stocks to buy this year. They're all down significantly from their all-time highs but still look…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    Best British growth stocks to buy for December

    | The Motley Fool Staff

    We asked our freelance writers to reveal the top growth shares they’d buy in December, which included a rare double…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    Is it time to buy Moderna shares?

    | Dr. James Fox

    Moderna shares have lost nearly 15% of their value over the last week. So is it time for me to…

    Read more »

    Investing Articles

    Is Moderna stock a buy?

    | Dan Appleby, CFA

    Moderna stock is rallying after a new strain of the Covid virus was announced. Dan Appleby looks at the company…

    Read more »

    Investing Articles

    What is the Moderna share price really worth?

    | Rupert Hargreaves

    Rupert Hargreaves explains why he thinks the Moderna share price is attractively priced after the company's recent declines.

    Read more »

    Investing Articles

    I think these 2 S&P 500 stocks are severely overvalued

    | Stuart Blair

    S&P 500 stocks have soared in recent times, reaching new highs day-by-day. But I now think that these two growth…

    Read more »

    Young lady working from home office during coronavirus pandemic.
    Investing Articles

    Should I buy Moderna for my Stocks and Shares ISA?

    | Rupert Hargreaves

    Rupert Hargreaves explains why he thinks the Moderna share price could be an attractive acquisition for his Stocks and Shares…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    Moderna shares are beating the rest of the S&P 500. Am I buying?

    | Stuart Blair

    Moderna shares have had a fantastic 2021, and have risen far more than the rest of the S&P 500. After…

    Read more »

    Investing Articles

    Can the Moderna share price keep rising?

    | Zaven Boyrazian, MSc

    The Moderna share price has surged more than 450% in 12 months. But this explosive growth may soon be over.…

    Read more »

    Investing Articles

    The Moderna share price has risen +400%: should I buy the stock now?

    | Charlie Keough

    With the continued vaccine rollout leading to a positive Q1, Charlie Keough assesses whether he sees long-term value in the…

    Read more »